IPS HEART
CA - San DiegoBiotechnology
Focus: IPS HEART is a San Diego-based biotechnology company founded in 2014 specializing in induced pluripotent stem cell (iPSC) cardiac therapies. As a public company, it operates in the emerging cell therapy and cardiovascular markets.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Should You Work at IPS HEART?
AI assessmentBest suited for early-career or mission-driven scientists comfortable with execution risk; limited near-term career acceleration for those seeking rapid scaling or established product portfolios.
Why Work Here
- You'll work at the forefront of regenerative medicine in cardiovascular disease, a high-impact therapeutic area with significant unmet patient need.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for IPS HEART
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.